Atossa Therapeutics, Inc.

ATOS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
3 May 8, 2014 PRIMARY DOCUMENT
4 May 8, 2014 PRIMARY DOCUMENT
4 May 8, 2014 PRIMARY DOCUMENT
8-K May 8, 2014 8-K
EFFECT Apr 25, 2014
EFFECT Apr 21, 2014
POS AM Apr 18, 2014 POS AM
POS AM Apr 15, 2014 FORM POS AM
DEF 14A Apr 11, 2014 DEF 14A
4 Apr 3, 2014 PRIMARY DOCUMENT
3 Apr 3, 2014 PRIMARY DOCUMENT
10-K Mar 27, 2014 FORM 10-K
8-K Mar 27, 2014 8-K
8-K Mar 5, 2014 8-K
4 Mar 4, 2014 PRIMARY DOCUMENT
3 Mar 4, 2014 PRIMARY DOCUMENT
5 Feb 14, 2014 PRIMARY DOCUMENT
5 Feb 14, 2014 PRIMARY DOCUMENT
S-8 Feb 14, 2014 S-8
8-K Feb 5, 2014 8-K
424B5 Jan 27, 2014 424B5
8-K Jan 24, 2014 8-K
424B5 Jan 23, 2014 FORM 424B5
4 Jan 9, 2014 PRIMARY DOCUMENT
8-K Dec 19, 2013 8-K
← Newer Page 21 of 26 · 643 filings Older →